SHREE GANESH REMEDIES
Back to Cashflow Statement
|
SHREE GANESH REMEDIES Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹7.21 Cr | ₹4.67 Cr | ₹0.42 Cr | ₹1.71 Cr | ₹0.76 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SHREE GANESH REMEDIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹7.21 Cr |
Mar2023 | ₹4.67 Cr |
Mar2022 | ₹0.42 Cr |
Mar2021 | ₹1.71 Cr |
Mar2020 | ₹0.76 Cr |
How is Net Cash Inflow / Outflow of SHREE GANESH REMEDIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹7.21 Cr | 54.27 | |
Mar2023 | ₹4.67 Cr | 1,020.14 | |
Mar2022 | ₹0.42 Cr | -75.64 | |
Mar2021 | ₹1.71 Cr | 125.26 | |
Mar2020 | ₹0.76 Cr | - |
Compare Net Cash Inflow / Outflow of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹1,040.2 Cr | 27.6% | 24.6% | 6.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,132.0 Cr | -2.4% | -7.2% | 27.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,254.0 Cr | 0% | -9.2% | 61.5% | Stock Analytics | |
CIPLA | ₹116,123.0 Cr | 6% | -3.8% | 10.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,573.0 Cr | 1.7% | -11.4% | 2.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,966.9 Cr | 5.2% | -2.1% | 26.1% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | 27.6% |
24.6% |
6.7% |
SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses